AHR and early-onset autosomal dominant Alzheimer disease: Dietary flavonoids have biochemical anticancer mechanisms by making the aryl hydrocarbon receptor (AhR) the target site [50] and similarly in Alzheimer's disease (AD) and atherosclerosis [51, 52] and chemoprevention and disease therapy [53].